Stay hydrated: Dehydration worsens GI symptoms across all GLP-1 class medications
Warnings: If you are pregnant, breast-feeding, have a medical condition or are under medical supervision, please consult a doctor before use Not suitable for use during planned pregnancy, pregnancy or breast-feeding Not suitable for children Contains sweetener(s) Do not exceed the recommended daily intake/dose Do not purchase or consume if the seal is broken Keep out of reach of children Food supplements should not be used as a substitute for a varied and balanced diet and healthy lifestyle Package label: Certification: Certified GMP Please Note: The product information on The Natural Dispensary website has been provided by the manufacturers and suppliers of these goods
Patients starting weight loss medication treatment at IconMD in Boston and Waltham can typically expect to see initial changes within a few weeks, but significant, sustained weight loss generally develops over a longer period
FDA Prescribing Information (official links): Tirzepatide (Mounjaro / Zepbound) Zepbound (FDA-approved for chronic weight management) / Mounjaro (FDA-approved for type 2 diabetes
64B15-14.004 Standards for Prescription of Obesity Drugs (Effective Aug 8, 2022)
Lillys triple agonist, retatrutide, delivered powerful weight loss in pivotal phase 3 obesity trial
